High risk and little knowledge: Overdose experiences and knowledge among young adult nonmedical prescription opioid users

International Journal of Drug Policy

Volumn 26, Issue 1, 2015, Pages 84-91

  Frank, David ^a,b   Mateu Gelabert, Pedro ^b   Guarino, Honoria ^b   Bennett, Alex ^b   Wendel, Travis ^c   Jessell, Lauren ^b   Teper, Anastasia ^b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^c St Ann s Corner of Harm Reduction   (United States)

Author keywords

Harm reduction; Naloxone; Nonmedical prescription opioid use; Overdose; Transition to heroin

Indexed keywords

ALCOHOL; NALOXONE; OPIATE; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST;

ADULT; ARTICLE; ATTITUDE TO HEALTH; AUDIO RECORDING; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DRUG OVERDOSE; DRUG SAFETY; EXPERIENCE; FEMALE; HEALTH; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HEALTH SERVICE; HEROIN DEPENDENCE; HIGH RISK POPULATION; HUMAN; MALE; MULTIPLE DRUG ABUSE; NONMEDICAL PRESCRIPTION OPIOID USE; OPIATE ADDICTION; SAFETY; SEMI STRUCTURED INTERVIEW; SYRINGE EXCHANGE PROGRAM; UNITED STATES; YOUNG ADULT; ADOLESCENT; DRUG MISUSE; GROUNDED THEORY; INTERVIEW; OPIOID-RELATED DISORDERS; PREVENTIVE HEALTH SERVICE; RISK; STATISTICS AND NUMERICAL DATA; SUBSTANCE ABUSE; UTILIZATION;

ADOLESCENT; ADULT; ANALGESICS, OPIOID; DRUG OVERDOSE; FEMALE; GROUNDED THEORY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERVIEWS AS TOPIC; MALE; NALOXONE; NARCOTIC ANTAGONISTS; NEEDLE-EXCHANGE PROGRAMS; NEW YORK CITY; OPIOID-RELATED DISORDERS; PRESCRIPTION DRUG MISUSE; RISK; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 84919871188     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2014.07.013     Document Type: Article

References (53)

1. Acker C.J. Creating the American junkie: Addiction research in the classic era of narcotic control 2002, John Hopkins University Press, Baltimore/London.
2. Albert S., Brason F., Sanford C., Dasgupta N., Graham J., Lovette B. Project lazarus: Community-based overdose prevention in rural North Carolina. Pain Medicine 2011, 12:577-585.
3. Bennett A.S., Bell A., Tomedi L., Hulsey E.G., Kral A.H. Characteristics of an overdose prevention, response, and naloxone distribution program in Pittsburgh and Allegheny County, Pennsylvania. Journal of Urban Health: Bulletin of the New York Academy of Medicine 2011, 88(6):1020-1030.
4. Bergschmidt V.B. Power, pleasure and dangerous substances: Applying Foucault to the study of 'heroin dependence' in Germany. Anthropology and Medicine 2004, 11(1):59-73.
5. Blending Initiative Buprenorphine treatment for young adults 2009, Retrieved June 17, 2014 from http://www.drugabuse.gov/sites/default/files/files/BupTx_YngAdlts_Factsheet.pdf.
6. Brands B., Paglia-Boak A., Sproule B.A., Leslie K., Adlaf E.M. Nonmedical use of opioid analgesics among Ontario students. Canadian Family Physician 2010, 56(3):256-262.
7. Brugal T., Barrio G., de la Fuente L., Regidor E., Royuela L., Suelves J. Factors associated with non-fatal heroin overdose: Assessing the effects of frequency and route of administration. Addiction 2002, 97(3):319-327.
8. Calcaterra S., Glanz J., Binswanger I.A. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009. Drug and Alcohol Dependence 2013, 131:263-270.
9. Centers for Disease Control and Prevention NCHS data brief number 81, drug poisoning deaths in the United States, 1980-2008 2011, Retrieved December 6, 2013, from: http://www.cdc.gov/nchs/data/databriefs/db81.htm.
10. Centers for Disease Control and Prevention (CDC) Community-based opioid overdose prevention programs providing naloxone-United States, 2010. MMWR. Morbidity and Mortality Weekly Report 2012, 61(6):101.
11. Charmaz K. Constructing grounded theory: A practical guide through qualitative analysis 2006, Sage, London.
12. Comer S., Sullivan M., Whittington R., Vosburg S., Kowalczyk W. Relative abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers. Neuropsychopharmacology 2008, 33(5):1179-1191.
13. Darke S., Zador D. Fatal heroin 'overdose': A review. Addiction 2006, 91(12):1765-1772.
14. Darke S., Hall W. Heroin overdose: Research and evidence-based intervention. Journal of Urban Health 2003, 80(2):189-200.
15. Doe-Simkins M., Walley A.Y., Epstein A., Moyer P. Saved by the nose: Bystander-administered intranasal naloxone hydrochloride for opioid overdose. American Journal of Public Health 2009, 99(5):788.
16. Drug Policy Alliance Implementing New York's 911 Good Samaritan Law 2013, Retrieved October 11, 2013, from: http://www.drugpolicy.org/departments-and-state-offices/new-york/implementing-new-yorks-911-good-samaritan-law.
17. Daniulaityte R., Falck R., Carlson R.G. I'm not afraid of those ones just 'cause they've been prescribed. International Journal of Drug Policy 2012, 23(5):374-384.
18. Fraser S., Hopwood M., Treloar C., Brener L. Needle fictions: Medical constructions of needle fixation and the injecting drug user. Addiction Research & Theory 2004, 12(1):67-76.
19. Galea S., Worthington N., Piper T.M., Nandi V.V., Curtis M., Rosenthal D.M. Provision of naloxone to injection drug users as an overdose prevention strategy: Early evidence from a pilot study in New York City. Addictive Behaviors 2006, 31:907-912.
20. Garfein R., Golub E., Greenberg A., Hagan H., Hanson D., Hudson S., et al. A peer-education intervention to reduce injection risk behaviors for HIV and hepetitus C infection in young injection drug users. AIDS 2007, 21(14):1923-1932.
21. Ghandour L.A., El Sayed D.S., Martins S.S. Prevalence and patterns of commonly abused psychoactive prescription drugs in a sample of university students from Lebanon: An opportunity for cross-cultural comparisons. Drug and Alcohol Dependence 2012, 121(1):110-117.
22. Glaser B.G., Strauss A.L. The discovery of grounded theory: Strategies for qualitative research 1967, Aldine, Chicago.
23. Gossop M., Griffiths P., Powis B., Williamson S., Strang J. Frequency of non-fatal heroin overdose: Survey of heroin users recruited in non-clinical settings. British Medical Journal 1996, 313(7054):402.
24. Green T.C., Black R., Serrano J.M.G., Budman S.H., Butler S.F. Typologies of prescription opioid use in a large sample of adults assessed for substance abuse treatment. PLoS ONE 2011, 6(11):e27244.
25. Heller D.I., Stancliff S. Providing naloxone to substance users for secondary administration to reduce overdose mortality in New York City. Public Health Reports 2007, 122(3):393.
26. Jann M., Kennedy W.K., Lopez G. Benzodiazepines a major component in unintentional prescription drug overdoses with opioid analgesics. Journal of Pharmacy Practice 2014, 27(1):5-16.
27. Jones J.D., Roux P., Stancliff S., Matthews W., Comer S.D. Brief overdose education can significantly increase accurate recognition of opioid overdose among heroin users. International Journal of Drug Policy 2014, 25(1):166-170.
28. Katz C., El-Gabalawy R., Keyes K.M., Martins S.S., Sareen J. Risk factors for incident nonmedical prescription opioid use and abuse and dependence: Results from a longitudinal nationally representative sample. Drug and Alcohol Dependence 2013, 132(1):107-113.
29. Kerr T., Fairbairn N., Tyndall M., Marsh D., Li K., Montaner J., et al. Predictors of non-fatal overdose among a cohort of polysubstance using injection drug users. Drug and Alcohol Dependence 2007, 87(1):39-45.
30. Kim D., Irwin K.S., Khoshnood K. Expanded access to naloxone: Options for critical response to the epidemic of opioid overdose mortality. American Journal of Public Health 2009, 99(3):402.
31. Lankenau S.E., Teti M., Silva K., Bloom J.J., Harocopos A., Treese M. Patterns of prescription drug misuse among young injection drug users. Journal of Urban Health 2012, 89(6):1004-1016.
32. Lankenau S.E., Teti M., Silva K., Bloom J.J., Harocopos A., Treese M. Initiation into prescription opioid misuse amongst young injection drug users. International Journal of Drug Policy 2012, 23(1):37-44.
33. Manderson D. Metamorphoses: Clashing symbols in the social construction of drugs. Journal of Drug Issues 1995, 25:799-816.
34. Mars S.G., Bourgois P., Karandinos G., Montero F., Ciccarone D. Every 'Never'I Ever Said Came True: Transitions from opioid pills to heroin injecting. International Journal of Drug Policy 2013, 25(2):257-266.
35. Moerman D.E. Meaning, medicine, and the "placebo effect" 2002, Vol. 28. Cambridge University Press, Cambridge.
36. National Association of State Alcohol and Drug Abuse Directors Overview of State Legislation to increase access to treatment for opioid overdose 2013, Retrieved April 7, 2014, from: http://nasadad.org/wp-content/uploads/2010/12/Opioid-Overdose-Policy-Brief-Final8.pdf.
37. National Institute on Drug Abuse Abuse of prescription (Rx) drugs affects young adults most 2013, Retrieved June 17, 2014 from: http://www.drugabuse.gov/related-topics/trends-statistics/infographics/abuse-prescription-rx-drugs-affects-young-adults-most.
38. Nielsen S., Bruno R., Lintzeris N., Fischer J., Carruthers S., Stoove M. Pharmaceutical opioid analgesic and heroin dependence: How do treatment-seeking clients differ in Australia?. Drug and Alcohol Review 2011, 30(3):291-299.
39. New York City Department of Health and Mental Hygiene Epi data brief: Unintentional drug poisoning (overdose) deaths in New York City 2000-2012. September, number 33 2013, Retrieved on April 7, 2014, from: http://www.nyc.gov/html/om/pdf/2013/edb_unintentional_drug_poisening_overdose_deaths.pdf.
40. New York City Department of Health and Mental Hygiene Prescription painkiller and heroin overdose deaths continue to rise in New York City. Press release: 003-14 2014, Retrieved March 11, 2014, from: http://www.nyc.gov/html/doh/html/pr2014/pr003-14.shtml.
41. New York Society of Addiction Medicine Overview of opioid overdose prevention programs in New York State 2011, Retrieved March 1, 2014, from: http://nysam-asam.com/public-policy/2011/5/17/overview-of-opioid-overdose-prevention-programs-in-new-york.html.
42. New York State Department of Health Expanded Syringe Access Program (ESAP): Overview of the law and regulations 2010, Retrieved December 1, 2013, from: http://www.health.ny.gov/diseases/aids/harm_reduction/needles_syringes/esap/overview.htm.
43. Ochoa K.C., Hahn J.A., Seal K.H., Moss A.R. Overdosing among young injection drug users in San Francisco. Addictive Behaviors 2001, 26(3):453-460.
44. Paulozzi L.J. Prescription drug overdoses: A review. Journal of Safety Research 2012, 43(4):283-289.
45. Preti A., Miotto P., De Coppi M. Deaths by unintentional illicit drug overdose in Italy, 1984-2000. Drug and Alcohol Dependence 2002, 66(3):275-282.
46. Sherman S.G., Gann D.S., Scott G., Carlberg S., Bigg D., Heimer R. A qualitative study of overdose responses among Chicago IDUs. Harm Reduction Journal 2008, 5(2):1-5.
47. Silva K., Schrager S.M., Kecojevic A., Lankenau S.E. Factors associated with history of non-fatal overdose among young non-medical users of prescription drugs. Drug and Alcohol Dependence 2013, 128:104-110.
48. Simmonds L., Coomber R. Injecting drug users: A stigmatised and stigmatising population. International Journal of Drug Policy 2009, 20(2):121-130.
49. Strang J., Manning V., Mayet S., Best D., Titherington E., Santana L., et al. Overdose training and take-home naloxone for opiate users: Prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction 2008, 103(10):1648-1657.
50. Warner M., Chen L.H., Makuc D.M., Anderson R.N., Minino A.M. National Center for Health Statistics Data Brief #81 2011, Retrieved February 12, 2014, from: http://www.cdc.gov/nchs/data/databriefs/db81.pdf.
51. Webster L.R., Cochella S., Dasgupta N., Fakata K.L., Fine P.G., Fishman S.M., et al. An analysis of the root causes for opioid-related overdose deaths in the United States. Pain Medicine 2011, 12(s2):S26-S35.
52. Werb D., Buxton J., Shoveller J., Richardson C., Rowell G., Wood E. Interventions to prevent the initiation of injection drug use: A systematic review. Drug and Alcohol Dependence 2013, 133(2):669-676.
53. Williams A.V., Strang J., Marsden J. Development of opioid overdose knowledge (OOKS) and attitudes (OOAS) scales for take-home naloxone training evaluation. Drug and Alcohol Dependence 2013, 132(1):383-386.